Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway
about
Transcriptional adaptations following exercise in thoroughbred horse skeletal muscle highlights molecular mechanisms that lead to muscle hypertrophyDEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoterStra13 is induced by genotoxic stress and regulates ionizing-radiation-induced apoptosisAbundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activationSTRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation markerAn Integrative Analysis of Preeclampsia Based on the Construction of an Extended Composite Network Featuring Protein-Protein Physical Interactions and Transcriptional RelationshipsStra13 homodimers repress transcription through class B E-box elementsBasic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stagesHelt, a novel basic-helix-loop-helix transcriptional repressor expressed in the developing central nervous systemBasic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1.Insulin induces the expression of the SHARP-2/Stra13/DEC1 gene via a phosphoinositide 3-kinase pathway.The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter.SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability.DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activities.Proteasomal degradation of O-GlcNAc transferase elevates hypoxia-induced vascular endothelial inflammatory response†.Bone muscle crosstalk targets muscle regeneration pathway regulated by core circadian transcriptional repressors DEC1 and DEC2.DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiationCellular and molecular responses of cultured neurons to stressful stimuliBhlhe40 Represses PGC-1α Activity on Metabolic Gene Promoters in Myogenic Cells.The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancersTwo novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors.Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancer.bHLH-Orange Transcription Factors in Development and Cancer.Kinetic analysis of genomewide gene expression reveals molecule circuitries that control T cell activation and Th1/2 differentiation.Prostaglandin F2alpha induces the normoxic activation of the hypoxia-inducible factor-1 transcription factor in differentiating 3T3-L1 preadipocytes: Potential role in the regulation of adipogenesisPI-3 kinase pathway can mediate the effect of TGF-beta1 in inducing the expression of SHARP-2 in LLC-PK1 cells.Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.The circadian clock and the hypoxic response pathway in kidney cancer.The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells.DEC1 coordinates with HDAC8 to differentially regulate TAp73 and ΔNp73 expression.Hypoxia and DNA repair.Regulation of basic helix-loop-helix transcription factors Dec1 and Dec2 by RORα and their roles in adipogenesis.Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.P/CAF rescues the Bhlhe40-mediated repression of MyoD transactivation.Embryo-chondrocyte expressed gene 1, downregulating hypoxia-inducible factor 1alpha, is another marker of lung tumor hypoxia.Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13.Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.Binding to Elongin C inhibits degradation of interacting proteins in yeast.Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL.SHARP-2/Stra13/DEC1 as a potential repressor of phosphoenolpyruvate carboxykinase gene expression.
P2860
Q21283740-C0DE847B-A627-472B-B92B-DD9B694B7D78Q24297161-7EBB326F-593C-4492-AD24-662AA53D920DQ24299485-CB27EDCD-7B4A-4508-AD89-83218BC9138AQ24534648-E8342919-B6D9-4FAE-88BD-E7FFD66DB213Q24673459-EC073012-FB52-4655-B18D-BCFC07A0E810Q28109684-C3579F4F-ADEC-4EA2-8131-202567B8C8C3Q28203742-524A472A-7BAB-4777-A66A-C6AC6F9DF8DCQ28207957-3D23287B-FA82-42F0-95B4-D538DF38D182Q28594530-A02F197F-7549-452E-A70D-4958BACCE8B2Q30484945-AF964B3E-DC1D-457A-80DA-13346895B87EQ33187328-9AF060BF-4580-46C2-B619-B429647F21C6Q33968314-35374E14-F867-4AC5-B493-43254B2389A0Q33988687-1B7B4947-0D60-4BE4-B223-7163A3BA9F8AQ34014701-0D576A5E-F45B-4F78-A635-FAAD51E97771Q34048268-4E9263B2-C9A8-42AD-8913-23442FA86C42Q34545181-2538C7CE-BD22-4355-A97C-E3748330111FQ34752036-725761FC-843E-49BF-AD9C-AA4412697ECDQ35270162-C30CA668-A494-4BE6-9769-23A0AC7B27BBQ35764224-15677AD7-A55D-44DD-A8DB-E028EC78943EQ36695552-E31FB593-2311-4EC9-BAFD-37E42DC41EF5Q36699730-133C777D-70A7-4386-B823-7F43E66184EEQ36710543-D7E96314-A7C6-41B5-9357-42CE85A11928Q36790868-78116BBD-2AB7-4E09-8DDC-79223017F79EQ36853486-5769EE79-F243-43B6-94DD-A6BAA9D8CAD8Q37080282-549D4B3A-A56D-4187-8E68-48BFEBFF2DB0Q37335214-3AAD4A32-76B5-48AE-B85A-562570EC9A50Q37617542-1F1CE428-2641-4824-8B61-A5F602089F7BQ38128792-A89F2CF6-5568-40C8-A15A-127FC11D608BQ38398088-60433B70-1648-438D-8335-A789FFD33A18Q39036140-FD45D18D-C7F3-47F6-AD8D-51B206DDEE43Q39042366-FAB0D93F-638B-4578-9954-3E96C1FC4D09Q39412627-8FCE0C2F-70D1-4363-84F9-7DCDC47B3362Q39604051-DE7636A9-4A83-442E-BF91-EECB2285FF26Q39838822-EE7FE6C3-826D-43D6-98AD-E5691E723934Q40156053-CE3B75F8-55AA-4791-AAEC-A56D374582C8Q40249807-2E53BD8F-E14F-44E0-8F8A-28EF08210185Q42066873-BBA69AAB-7AD6-4E0F-B0D8-690A1B807F9DQ43895788-988C19E3-5497-4BBF-98DB-59592061580BQ44922990-20406ADF-3928-4964-BAE9-B56C30731588Q45284394-7A579B6F-6F5B-4AAF-A333-4A84716CFF09
P2860
Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@ast
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@en
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@en-gb
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@nl
type
label
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@ast
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@en
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@en-gb
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@nl
prefLabel
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@ast
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@en
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@en-gb
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@nl
P2093
P2860
P3181
P356
P1476
Regulation of STRA13 by the vo ...... proteasome degradation pathway
@en
P2093
A Danilkovitch-Miagkova
A V Ivanova
M I Lerman
S V Ivanov
P2860
P304
P3181
P356
10.1074/JBC.M010516200
P407
P577
2001-05-04T00:00:00Z